Literature DB >> 22492660

A simulation study of finite-sample properties of marginal structural Cox proportional hazards models.

Daniel Westreich1, Stephen R Cole, Enrique F Schisterman, Robert W Platt.   

Abstract

Motivated by a previously published study of HIV treatment, we simulated data subject to time-varying confounding affected by prior treatment to examine some finite-sample properties of marginal structural Cox proportional hazards models. We compared (a) unadjusted, (b) regression-adjusted, (c) unstabilized, and (d) stabilized marginal structural (inverse probability-of-treatment [IPT] weighted) model estimators of effect in terms of bias, standard error, root mean squared error (MSE), and 95% confidence limit coverage over a range of research scenarios, including relatively small sample sizes and 10 study assessments. In the base-case scenario resembling the motivating example, where the true hazard ratio was 0.5, both IPT-weighted analyses were unbiased, whereas crude and adjusted analyses showed substantial bias towards and across the null. Stabilized IPT-weighted analyses remained unbiased across a range of scenarios, including relatively small sample size; however, the standard error was generally smaller in crude and adjusted models. In many cases, unstabilized weighted analysis showed a substantial increase in standard error compared with other approaches. Root MSE was smallest in the IPT-weighted analyses for the base-case scenario. In situations where time-varying confounding affected by prior treatment was absent, IPT-weighted analyses were less precise and therefore had greater root MSE compared with adjusted analyses. The 95% confidence limit coverage was close to nominal for all stabilized IPT-weighted but poor in crude, adjusted, and unstabilized IPT-weighted analysis. Under realistic scenarios, marginal structural Cox proportional hazards models performed according to expectations based on large-sample theory and provided accurate estimates of the hazard ratio.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22492660      PMCID: PMC3641777          DOI: 10.1002/sim.5317

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  33 in total

1.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Adjusted survival curves with inverse probability weights.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Comput Methods Programs Biomed       Date:  2004-07       Impact factor: 5.428

3.  A definition of causal effect for epidemiological research.

Authors:  M A Hernán
Journal:  J Epidemiol Community Health       Date:  2004-04       Impact factor: 3.710

4.  Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study.

Authors:  Nancy R Cook; Stephen R Cole; Charles H Hennekens
Journal:  Am J Epidemiol       Date:  2002-06-01       Impact factor: 4.897

5.  Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.

Authors:  M A Albrecht; R J Bosch; S M Hammer; S H Liou; H Kessler; M F Para; J Eron; H Valdez; M Dehlinger; D A Katzenstein
Journal:  N Engl J Med       Date:  2001-08-09       Impact factor: 91.245

6.  Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.

Authors:  Hyon K Choi; Miguel A Hernán; John D Seeger; James M Robins; Frederick Wolfe
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

7.  Time scale and adjusted survival curves for marginal structural cox models.

Authors:  Daniel Westreich; Stephen R Cole; Phyllis C Tien; Joan S Chmiel; Lawrence Kingsley; Michele Jonsson Funk; Kathryn Anastos; Lisa P Jacobson
Journal:  Am J Epidemiol       Date:  2010-02-05       Impact factor: 4.897

8.  Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán; James M Robins; Kathryn Anastos; Joan Chmiel; Roger Detels; Carolyn Ervin; Joseph Feldman; Ruth Greenblatt; Lawrence Kingsley; Shenghan Lai; Mary Young; Mardge Cohen; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2003-10-01       Impact factor: 4.897

9.  Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy.

Authors:  Yolanda Barrón; Stephen R Cole; Ruth M Greenblatt; Mardge H Cohen; Kathryn Anastos; Jack A DeHovitz; Robert Delapenha; Stephen J Gange
Journal:  AIDS       Date:  2004-07-23       Impact factor: 4.177

10.  Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology.

Authors:  Lisa M Bodnar; Marie Davidian; Anna Maria Siega-Riz; Anastasios A Tsiatis
Journal:  Am J Epidemiol       Date:  2004-05-15       Impact factor: 4.897

View more
  13 in total

Review 1.  Treatment decisions in multiple sclerosis - insights from real-world observational studies.

Authors:  Maria Trojano; Mar Tintore; Xavier Montalban; Jan Hillert; Tomas Kalincik; Pietro Iaffaldano; Tim Spelman; Maria Pia Sormani; Helmut Butzkueven
Journal:  Nat Rev Neurol       Date:  2017-01-13       Impact factor: 42.937

Review 2.  Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa.

Authors:  Holly Janes; Lawrence Corey; Gita Ramjee; Lindsay N Carpp; Carl Lombard; Myron S Cohen; Peter B Gilbert; Glenda E Gray
Journal:  AIDS Res Hum Retroviruses       Date:  2018-06-19       Impact factor: 2.205

3.  Causal inference in occupational epidemiology: accounting for the healthy worker effect by using structural nested models.

Authors:  Ashley I Naimi; David B Richardson; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2013-09-27       Impact factor: 4.897

4.  Simulation from a known Cox MSM using standard parametric models for the g-formula.

Authors:  Jessica G Young; Eric J Tchetgen Tchetgen
Journal:  Stat Med       Date:  2013-10-22       Impact factor: 2.373

5.  Propensity Score Weighting Compared to Matching in a Study of Dabigatran and Warfarin.

Authors:  John D Seeger; Katsiaryna Bykov; Dorothee B Bartels; Krista Huybrechts; Sebastian Schneeweiss
Journal:  Drug Saf       Date:  2017-02       Impact factor: 5.606

6.  Comparison of methods for estimating the effect of salvage therapy in prostate cancer when treatment is given by indication.

Authors:  Jeremy M G Taylor; Jincheng Shen; Edward H Kennedy; Lu Wang; Douglas E Schaubel
Journal:  Stat Med       Date:  2013-07-03       Impact factor: 2.373

7.  Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort.

Authors:  Mohammad Ehsanul Karim; Paul Gustafson; John Petkau; Yinshan Zhao; Afsaneh Shirani; Elaine Kingwell; Charity Evans; Mia van der Kop; Joel Oger; Helen Tremlett
Journal:  Am J Epidemiol       Date:  2014-06-17       Impact factor: 4.897

Review 8.  Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches.

Authors:  Chelsea B Polis; Daniel Westreich; Jennifer E Balkus; Renee Heffron
Journal:  AIDS       Date:  2013-10       Impact factor: 4.177

9.  SIMULATION IN PRACTICE: THE BALANCING INTERCEPT.

Authors:  Jacqueline E Rudolph; Jessie K Edwards; Ashley I Naimi; Daniel J Westreich
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

10.  Estimating multiple time-fixed treatment effects using a semi-Bayes semiparametric marginal structural Cox proportional hazards regression model.

Authors:  Stephen R Cole; Jessie K Edwards; Daniel Westreich; Catherine R Lesko; Bryan Lau; Michael J Mugavero; W Christopher Mathews; Joseph J Eron; Sander Greenland
Journal:  Biom J       Date:  2017-10-27       Impact factor: 2.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.